I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Case Report: Targeting of individual somatic tumor mutation..:
Henning Zelba
;
Armin Rabsteyn
;
Oliver Bartsch
...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1271449/full. , 2023
Link:
https://doi.org/10.3389/fimmu.2023.1271449
RT Journal T1
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:a73d96006989470ca02025d8a8342028&Exemplar=1&LAN=DE A1 Henning Zelba A1 Armin Rabsteyn A1 Oliver Bartsch A1 Christina Kyzirakos A1 Simone Kayser A1 Marcel Seibold A1 Johannes Harter A1 Pauline Latzer A1 Dirk Hadaschik A1 Florian Battke A1 Alexander Golf A1 Matthew B. Rettig A1 Saskia Biskup PB Frontiers Media S.A. YR 2023 K1 prostate cancer K1 neoantigen K1 peptide K1 vaccination K1 APC K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2023.1271449/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2023.1271449 DO https://doi.org/10.3389/fimmu.2023.1271449 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)